First Wave’s mid-stage tri­al for yeast-de­rived cys­tic fi­bro­sis drug ‘like­ly’ failed, com­pa­ny says

First Wave Bio­Phar­ma’s at­tempt to best the cur­rent treat­ment op­tion for ex­ocrine pan­cre­at­ic in­suf­fi­cien­cy in cys­tic fi­bro­sis has “like­ly” failed.

Thurs­day morn­ing, the Bo­ca Ra­ton …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER